Interim clinical considerations for use of JYNNEOS and ACAM2000 vaccines during the 2022 U.S. monkeypox outbreak : Vaccine administration errors and deviations

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Interim clinical considerations for use of JYNNEOS and ACAM2000 vaccines during the 2022 U.S. monkeypox outbreak : Vaccine administration errors and deviations

[PDF-138.81 KB]

English

Details Supporting Files Related Documents You May Also Like

Details:

Corporate Authors:

National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology.
Description:

Updated August 15, 2022

Formerly called: Interim clinical considerations for use of JYNNEOS and ACAM2000 vaccines during the 2022 U.S. monkeypox outbreak : Vaccination strategies.

Interim recommendations for vaccine administration errors and deviations are summarized in the table below.

Table 7. Interim recommendations for JYNNEOS vaccine administration errors and deviations.
Content Notes:

Vaccines -- Vaccination Strategies -- Table 1. Vaccination Strategies Used in the 2022 U.S. Monkeypox Outbreak -- Planning Considerations for Health Departments and Providers -- Health Equity -- Table of Contents -- Resources .
Subjects:

[+]

Mpox (monkeypox)/prevention & Control Smallpox Vaccine Vaccination
Series:

Interim clinical considerations for use of JYNNEOS and ACAM2000 vaccines during the 2022 U.S. monkeypox outbreak
Document Type:

Webpage
Name as Subject:

ACAM2000® ; JYNNEOS® ; ACAM2000® ; JYNNEOS®

ACAM2000® ; JYNNEOS® ; ACAM2000® ; JYNNEOS® Less -
Collection(s):

Stephen B. Thacker CDC Library collection
Main Document Checksum:

[+]

urn:sha256:3e9513f7292248e81afa0ee24c5163cc01289304940dd8aefab52dcd018428bd
Download URL:

https://stacks.cdc.gov/view/cdc/120268/cdc_120268_DS1.pdf
File Type:

overview.html

htm

More +

Interim clinical considerations for use of JYNNEOS and ACAM2000 vaccines during the 2022 U.S. monkeypox outbreak : Vaccination strategies

[PDF - 357.04 KB]

:

National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology.

August 9, 2022 | Interim clinical considerations for use of JYNNEOS and ACAM2000 vaccines during the 2022 U.S. monkeypox outbreak

Description:

Two vaccines may be used for the prevention of monkeypox disease:• JYNNEOS vaccine is used for the prevention of smallpox and monkeypox disease amon...

Status:

superseded

File Type:

[PDF - 357.04 KB]

File Type:

[PDF - 357.04 KB]